@OracleNYSE Nah bro this is fake news. There is virtually zero chance $NVO acquires $VKTX. CagriSema only mildly underperforms VK2735 and will be FDA approved soon + it would trigger an immediate aggressive antitrust review by the FTC and DOJ
@A_May_MD This was very poor timing for an offering imo. $VKTX was ready to explode above $43 within maybe a few days if you look at the chart. It would have went past $60+ easily. Now they're stuck in the 25-40 range again.
For anyone still wondering why $NVO keeps selling off, this is part of the problem. Multiple agents beat semaglutide 2.4 mg (slide 1), semaglutide 7.2 mg (slide 2) and CagriSema (slide 3) on the weight-loss/tolerability trade-off.
And then observe how $LLY tirezpatide is performing. Literally nothing beats it on weight loss vs vomiting. This is why $NVO is losing the obesity market.
The one drug that has a realistic chance of beating tirzepatide on the overall profile is VK2735. And today $VKTX showed something beyond efficacy: optionality. VK2735 may be able to address a real unmet need in obesity treatment: maintaining weight with less frequent dosing and excellent tolerability.
That is what Novo needs. As $NVO CEO Mike Doustdar himself told Albert Bourla during the $MTSR bidding war: “put your hand in the pocket and bid higher.” Time to take your own medicine, Mike.
@avidresearch $LLY incretin portfolio as a whole is worth 80% of their market cap (the CEO said this himself). So tirz + reta combined is worth $800B+. VK2735 outperforms both of em and has oral formulation. My prediction is that Viking will be acquired by either Merck or AbbVie by end of year
After careful consideration and reviewing the current eligibility guidelines,
I’m officially declaring myself a @WNBA prospect.
If simply declaring who you are is all that’s required, then I meet every single requirement necessary to compete in the WNBA.
My team and I have carefully examined the WNBA’s eligibility criteria and governing framework surrounding self-identification and inclusion. Based on the current guidelines, I can and am officially declaring my eligibility for the upcoming WNBA draft in April 2027.
I know my presence on the court will stir up strong opinions.
I am definitely not here to mock, make fun of, or disrespect any community or personal choices.
I’m simply asking that the current rules be applied equally to everyone — the rules that represent the very values many WNBA players and coaches have publicly advocated for.
My team and I are prepared to ensure these guidelines are applied equally, consistently, and without exception, and I look forward to the #WNBA honoring its stated principles.
See you at training camp.
https://t.co/zlwWpVF0Ou
so let me get this straight here:
Sneako, who’s jewish, accused Nick of being Jewish, and now Dan Blizerian, who’s jewish, is attacking Nick because he thinks Nick is jewish
I thought I was done when the season ended. I wasn't ready to announce it, and I knew I needed some time to really decide, but I was pretty sure I played my last game. I was honest at that last press conference when I said I needed to look at myself and deicide if I still love
BREAKING: LeBron James is signing with the Philadelphia 76ers on a two-year, $8 million deal with a player option, Klutch Sports Group and Klutch CEO and Game Over show host Rich Paul tells ESPN.